Smith & Nephew (SNN) Other Non Operating Income (2009 - 2025)
Smith & Nephew (SNN) posted quarterly Other Non Operating Income of -$16.0 million for Q4 2025, up 42.86% year-on-year from -$11.2 million in Q4 2024, and up 42.86% on a QoQ basis from -$28.0 million in Q4 2024.
Smith & Nephew (SNN) Other Non Operating Income (2009 - 2025) Analysis & Trends
Smith & Nephew (SNN) has reported Other Non Operating Income for 17 consecutive years, with -$16.0 million the latest figure, recorded in Q4 2025.
- Quarterly Other Non Operating Income rose 42.86% year-over-year to -$16.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$42.0 million (down 20.0% YoY) and the FY2025 annual result came in at -$16.0 million, up 42.86% from the prior year.
- Other Non Operating Income improved to -$16.0 million in Q4 2025 per SNN's latest filing, from -$28.0 million in the prior quarter.
- Over the last five years, Other Non Operating Income for SNN reached as high as $7.0 million in Q4 2023 and fell as low as -$28.0 million in Q4 2024.
- A 5-year average of -$10.2 million and a median of -$9.0 million in 2021 frame the typical range for Other Non Operating Income.
- Annual changes were most pronounced in 2023 — Other Non Operating Income surged 240.0% — and 2024, when it sank 500.0%.
- Year by year, Other Non Operating Income stood at -$9.0 million in 2021, then surged by 44.44% to -$5.0 million in 2022, then jumped by 240.0% to $7.0 million in 2023, then plunged by 500.0% to -$28.0 million in 2024, then jumped by 42.86% to -$16.0 million in 2025.
- According to Business Quant data, Other Non Operating Income over the past three periods registered -$16.0 million, -$28.0 million, and $7.0 million for Q4 2025, Q4 2024, and Q4 2023 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Steris | 20.59 Bn | 20.16 Bn | 697.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -16.00 Mn |
| Dec 31, 2024 | -28.00 Mn |
| Dec 31, 2023 | 7.00 Mn |
| Dec 31, 2022 | -5.00 Mn |
| Dec 31, 2021 | -9.00 Mn |
| Dec 31, 2020 | -5.00 Mn |
| Dec 31, 2019 | -18.00 Mn |
| Dec 31, 2018 | -20.00 Mn |
| Dec 31, 2017 | -10.00 Mn |
| Dec 31, 2016 | -16.00 Mn |
| Dec 31, 2015 | -15.00 Mn |
| Dec 31, 2014 | -11.00 Mn |
| Sep 30, 2014 | -2.00 Mn |
| Mar 31, 2014 | -4.00 Mn |
| Dec 31, 2013 | -11.00 Mn |
| Mar 31, 2013 | -4.00 Mn |
| Dec 31, 2012 | -11.00 Mn |
| Jun 30, 2012 | -4.00 Mn |
| Mar 31, 2012 | -2.00 Mn |
| Dec 31, 2011 | -6.00 Mn |